The estimated population frequency for BRCA1/2 mutations (0.024 to 0.04%) in recessive and polygenic models, respectively [27], is held responsible for 5 to10 percent of all breast cancers and 10 to 15 percent of all ovarian cancer risk [23]. This evidence concerns the gene BRCA1 and breast carcinoma.